Author:
Waye Arianna,Chuck Anderson W.,Jacobs Philip,Tyrrell Gregory,Kellner James D.
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. World Health Organization. 23-Valent pneumococcal polysaccharide vaccine: WHO position paper. Wkly Epidemiol Rec. 2008;83(42):100–19.
2. Morrow A, De Wals P, Petit G, Guay M, Erickson LJ. The burden of pneumococcal disease in the Canadian population before routine use of the seven-valent pneumococcal conjugate vaccine. Can J Infect Dis Med Microbiol. 2007;18(2):121–7.
3. Kellner JD, Vanderkooi OG, MacDonald J, Church DL, Tyrrell GJ, Scheifele D. Changing epidemiology of invasive pneumococcal disease in Canada 1998 to 2007: update from the Calgary Area Streptococcus pneumoniae Research (CASPER) study. Can J Infect Dis. 2009;49:205–12.
4. Chuck A, Jacobs P, Nguyen T, Hanrahan A, Loewen J, Mashinter L, et al. Economic analysis of a public program for routine seven valent pneumococcal conjugate vaccine (PCV-7) in infancy, Alberta. Can Commun Dis Rep. 2008;34(10):1–13.
5. Chuck AW, Jacobs P, Tyrrell G, Kellner JD. Pharmacoeconomic evaluation of 10- and 13-valent pnumococcal conjugate vaccines. Vaccine. 2010;28:5484–90.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献